Towards a Patient-Centred Regulation of Gamete Donation in Canada.


Journal

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
ISSN: 1701-2163
Titre abrégé: J Obstet Gynaecol Can
Pays: Netherlands
ID NLM: 101126664

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 06 03 2019
revised: 18 05 2019
accepted: 23 05 2019
pubmed: 28 7 2019
medline: 15 9 2020
entrez: 27 7 2019
Statut: ppublish

Résumé

Commercial gamete donation in Canada is prohibited by the Assisted Human Reproduction Act. However, the Act permits gamete recipients to reimburse donors for donation-related expenses. Until recently, the types of expenses that were eligible and the process for reimbursing donors were not specified. In 2016, Health Canada announced its intent to develop regulations that would regulate gamete donor reimbursement; it released the proposed policy in 2017. As a result of consultations with Canadian lawmakers, physicians, and patients, debates surrounding commercial gamete donation are being revisited. Considering the ethical implications of gamete donation payment arrangements, a patient-centred care framework is useful going forward in the regulation of this practice. Patient-centred values of communication, respecting relational autonomy, and respecting patient interests should guide decisions regarding regulation of gamete donation arrangements in Canada.

Identifiants

pubmed: 31345737
pii: S1701-2163(19)30591-2
doi: 10.1016/j.jogc.2019.05.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1338-1340

Informations de copyright

Copyright © 2019 The Society of Obstetricians and Gynaecologists of Canada/La Société des obstétriciens et gynécologues du Canada. Published by Elsevier Inc. All rights reserved.

Auteurs

Mary Henein (M)

Biomedical Ethics Unit, McGill University, Montréal, QC; Department of Family Medicine, McGill University, Montréal, QC. Electronic address: mary.henein@mail.mcgill.ca.

Carolyn Ells (C)

Biomedical Ethics Unit, McGill University, Montréal, QC; Department of Family Medicine, McGill University, Montréal, QC; Department of Medicine, McGill University, Montréal, QC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH